輸液市場：タイプ別、組成液-2023～2030年の世界予測

輸液の世界市場は、2023年に137億6,000万米ドル、CAGR 9.10%で大きく成長し、2030年には253億8,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の輸液市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.輸液の世界市場規模および予測は？

2.予測期間中、世界の輸液市場を形成するCOVID-19の阻害要因と影響は？

3.輸液の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.輸液の世界市場における競争戦略は？

5.輸液の世界市場における技術動向と規制の枠組みは？

6.輸液の世界市場における主要ベンダーの市場シェアは？

7.輸液の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 胃腸障害、がん、神経疾患などの慢性・急性疾患の発生率の増加
    • 静脈内溶液注射に対する規制当局の承認の増加
    • 製品ポートフォリオを強化するためにメーカー間の戦略的提携が増加
  • 抑制要因
    • 液体のメンテナンスに高額なコストがかかる
  • 機会
    • 新興経済諸国からの輸液に対する需要の増加
    • 患者の利便性を追求した製品の改良と新たな革新
    • 大腸がん患者に対するビタミンC点滴の実施
  • 課題
    • 静脈内輸液の副作用
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 輸液市場：タイプ別

• イントロダクション
• 末梢非経口栄養
• 完全非経口栄養

第7章 輸液市場：組成液別

• イントロダクション
• 炭水化物
• デキストラン
• ヘパリンと微量元素
• 非経口脂質エマルジョン
• 単回投与アミノ酸溶液
• ビタミンとミネラル

第8章 南北アメリカの輸液市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の輸液市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの輸液市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
• FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2022 VS 2030
• FIGURE 3. INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2022 VS 2030 (%)
• FIGURE 6. INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
• FIGURE 8. INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 8. INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 100. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 101. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 102. INTRAVENOUS SOLUTIONS MARKET LICENSE & PRICING

The Global Intravenous Solutions Market is forecasted to grow significantly, with a projected USD 13.76 billion in 2023 at a CAGR of 9.10% and expected to reach a staggering USD 25.38 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Intravenous Solutions Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Intravenous Solutions Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Peripheral Parenteral Nutrition and Total Parenteral Nutrition. The Peripheral Parenteral Nutrition commanded largest market share of 72.52% in 2022, followed by Total Parenteral Nutrition.

Based on Composition Solution, market is studied across Carbohydrates, Dextran, Heparin & Trace Element, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Vitamins & Minerals. The Dextran commanded largest market share of 22.81% in 2022, followed by Parenteral Lipid Emulsion.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.64% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Intravenous Solutions Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Intravenous Solutions Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Intravenous Solutions Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Intravenous Solutions Market?

4. What is the competitive strategic window for opportunities in the Global Intravenous Solutions Market?

5. What are the technology trends and regulatory frameworks in the Global Intravenous Solutions Market?

6. What is the market share of the leading vendors in the Global Intravenous Solutions Market?

7. What modes and strategic moves are considered suitable for entering the Global Intravenous Solutions Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Intravenous Solutions Market, by Type, 2022 vs 2030
• 4.3. Intravenous Solutions Market, by Composition Solution, 2022 vs 2030
• 4.4. Intravenous Solutions Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
    • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
    • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Maintenance of Fluids
  • 5.1.3. Opportunities
    • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
    • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
    • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
  • 5.1.4. Challenges
    • 5.1.4.1. Side Effects of Intravenous Fluids
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Intravenous Solutions Market, by Type

• 6.1. Introduction
• 6.2. Peripheral Parenteral Nutrition
• 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

• 7.1. Introduction
• 7.2. Carbohydrates
• 7.3. Dextran
• 7.4. Heparin & Trace Element
• 7.5. Parenteral Lipid Emulsion
• 7.6. Single Dose Amino Acid Solution
• 7.7. Vitamins & Minerals

8. Americas Intravenous Solutions Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Intravenous Solutions Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Solutions Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing